Radient Pharma (RXPC) Approves 1-to-25 Reverse Split
Tweet
Share
E-mail
Radient Pharmaceuticals Corporation (OTCBB: RXPC), reports its Board of Directors has authorized the implementation of a 1:25 reverse split of the Company's outstanding common shares, which will be completed on or before January 15, 2012.
Authority for the reverse split was granted to the Board by the Company's stockholders at a November 4, 2011, special meeting.
Authority for the reverse split was granted to the Board by the Company's stockholders at a November 4, 2011, special meeting.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rapid Line sees stock surge with no known corporate cause
- Merit Medical names new EVP of global operations as COO prepares to exit
- IsoEnergy and Disa Technologies close deal to form Disa Uranium Corp
Create E-mail Alert Related Categories
Corporate News, Stock SplitsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
